# Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Study · id `cardio:ct-nct02649946` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02649946](<https://clinicaltrials.gov/study/NCT02649946>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02649946

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.

## Technical summary

Registry record NCT02649946. Randomized; no masking; primary purpose treatment. Start 2016-06 (actual); primary completion 2018-08 (actual). Results posted on 2019-05-13.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 280 participants (enrolled count; ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Started: 2016-06 (actual) (ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Primary completion: 2018-08 (actual) (ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Completion: 2021-02 (actual) (ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Results first posted: 2019-05-13 (ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Belgium; Germany; Netherlands; New Zealand; Switzerland (ClinicalTrials.gov record NCT02649946, source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02649946-2021-12-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
- Acronym: AVeNEW
- Condition: Stenosis
- Condition: Restenosis
- Intervention (Device): Covera Vascular Covered Stent following PTA
- Intervention (Procedure): Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon
- Lead sponsor: C. R. Bard
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: C. R. Bard (`cardio:org-c-r-bard`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis (`cardio:pubmed-36990214`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e6c29d9e95b4cc6007a28d1cdab1132bc56e86e3e130733c34ced041ace1b23a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
